WeVote
Log In

Bill

Bill

B 26-0159

PrEP DC Act of 2025

26th Council Period (2025-2026) Introduced by Zachary Parker

D.C. bill expands preventive HIV medication (PrEP) access to reduce transmission and address health equity barriers through insurance, provider, and funding reforms.

Law Number L26-0115 Effective from May 21, 2026
0
WeVote Research Nonpartisan
Bill Summary · B 26-0159

Legislative bill overview

The PrEP DC Act of 2025 expands access to pre-exposure prophylaxis (PrEP), a preventive medication that reduces HIV transmission risk. The bill appears to address barriers to PrEP availability and affordability in Washington, D.C., though specific provisions are not detailed in the legislative record provided.

Why is this important

PrEP is a well-established public health tool that can significantly reduce new HIV infections when access is equitable. Barriers to PrEP—including cost, stigma, and limited provider availability—disproportionately affect marginalized communities, making access legislation relevant to health equity and disease prevention outcomes.

Potential points of contention

  • Cost and funding mechanisms: Whether the bill adequately funds PrEP provision and how costs are distributed among insurance, Medicaid, and uninsured populations
  • Provider requirements and training: Potential debate over whether pharmacists, nurse practitioners, or only physicians can prescribe, and associated training requirements
  • Privacy and confidentiality protections: Concerns about medical record access, insurance documentation, and stigma-related confidentiality safeguards

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.